Inogen announces fourth quarter and full year 2021 financial results

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended december 31, 2021. fourth quarter 2021 highlights total revenue of $76.4 million, up 3.3% from the same period in 2020, in line with the mid-point of its preliminary, unaudited revenue estimate provided on january 10, 2022 domestic direct-to-consumer reve
INGN Ratings Summary
INGN Quant Ranking